Cargando…
Targeting energy metabolism via the mitochondrial pyruvate carrier as a novel approach to attenuate neurodegeneration
Several molecular pathways are currently being targeted in attempts to develop disease-modifying therapies to slow down neurodegeneration in Parkinson’s disease. Failure of cellular energy metabolism has long been implicated in sporadic Parkinson’s disease and recent research on rare inherited forms...
Autores principales: | Quansah, Emmanuel, Peelaerts, Wouter, Langston, J. William, Simon, David K., Colca, Jerry, Brundin, Patrik |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5968614/ https://www.ncbi.nlm.nih.gov/pubmed/29793507 http://dx.doi.org/10.1186/s13024-018-0260-x |
Ejemplares similares
-
Treating fatty liver disease by modulating mitochondrial pyruvate metabolism
por: Colca, Jerry R., et al.
Publicado: (2017) -
The Multifaceted Pyruvate Metabolism: Role of the Mitochondrial Pyruvate Carrier
por: Zangari, Joséphine, et al.
Publicado: (2020) -
Mitochondrial pyruvate carrier inhibition initiates metabolic crosstalk to stimulate branched chain amino acid catabolism
por: Ferguson, Daniel, et al.
Publicado: (2023) -
Inhibition of the mitochondrial pyruvate carrier simultaneously mitigates hyperinflammation and hyperglycemia in COVID-19
por: Zhu, Bibo, et al.
Publicado: (2023) -
The Importance of Mitochondrial Pyruvate Carrier in Cancer Cell Metabolism and Tumorigenesis
por: Ruiz-Iglesias, Ainhoa, et al.
Publicado: (2021)